Latest presentation

Second quarter 2018 results

Loading video...

Biotec Pharmacon: Results for Q2 2018 (Tromsø, August 16 2018) Biotec Pharmacon ASA (”Biotec”, OSE: BIOTEC) reported sales of NOK 10.9 million (16.4) in the second quarter of 2018, and a negative EBITDA of NOK 4.2 million (-4.4). ArcticZymes generated sales of NOK 5.7 million during the second quarter whereas Woulgan® generated…

View more